How much is Edgewise Therapeutics worth in 2026?

Edgewise Therapeutics has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Edgewise Therapeutics raised?

Edgewise Therapeutics has raised N/A in total funding across 2 funding rounds.

Edgewise Therapeutics

Drug Discovery

Edgewise Therapeutics valuation and funding history | Last updated: February 14, 2022 | 2 funding rounds

Current Valuation

N/A

As of February 14, 2022

Total Funding Raised

N/A

Across 2 rounds

Last Round

PIPE

Amount undisclosed

Last Funding

Feb 2022

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 14, 2022	PIPE	Undisclosed	N/A	-
December 8, 2020	Later Stage VC (Series C)	$95.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Edgewise Therapeutics is currently valued at N/A as of February 14, 2022.

Track Edgewise Therapeutics Valuation Updates

Get notified when Edgewise Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Edgewise Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Edgewise Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Edgewise Therapeutics Worth in 2026?

Edgewise Therapeutics is a leading private company in the Drug Discovery sector. Track Edgewise Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Edgewise Therapeutics Valuation is Determined

Private company valuations like Edgewise Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.